Diclazuril
CAS No. 101831-37-2
Diclazuril ( Clinacox | DCL | Diclazuril | R64-433 | R64433 )
产品货号. M10087 CAS No. 101831-37-2
Diclazuril (R-64433),苯乙腈衍生物,是一种有效的,具有口服活性的抗球虫剂 (anticoccidial agent)。Diclazuril (R-64433) 可用于某些传染病和寄生虫病的相关研究,如球虫病、急性弓形体病、马源虫性脑脊髓炎 (EPM) 等。
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 50MG | ¥365 | 有现货 |
|
| 100MG | ¥518 | 有现货 |
|
| 200MG | ¥786 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称Diclazuril
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述Diclazuril (R-64433),苯乙腈衍生物,是一种有效的,具有口服活性的抗球虫剂 (anticoccidial agent)。Diclazuril (R-64433) 可用于某些传染病和寄生虫病的相关研究,如球虫病、急性弓形体病、马源虫性脑脊髓炎 (EPM) 等。
-
产品描述Diclazuril is an anti-coccidial drug.(In Vivo):Diclazuril (R-64433) is a coccidiostat, the lambs treated with diclazuril showed an intense, persistent oocyst excretion, with average levels of 97.54 opg, considerably higher than those recorded in the animals treated with toltrazuril (p < 0.05). Diclazuril (R-64433) is effective against E. maxima later in its life cycle, subclinical intestinal lesions may be present for a short time after infection. Diclazuril (R-64433) was shown in studies to reduce lesion scores and improve performance and health of birds challenged with E. maxima.
-
体外实验——
-
体内实验Diclazuril (R-64433) is a coccidiostat, the lambs treated with diclazuril showed an intense, persistent oocyst excretion, with average levels of 97.54 opg, considerably higher than those recorded in the animals treated with toltrazuril (p < 0.05). Diclazuril (R-64433) is effective against E. maxima later in its life cycle, subclinical intestinal lesions may be present for a short time after infection. Diclazuril (R-64433) was shown in studies to reduce lesion scores and improve performance and health of birds challenged with E. maxima.
-
同义词Clinacox | DCL | Diclazuril | R64-433 | R64433
-
通路Others
-
靶点Other Targets
-
受体Others
-
研究领域Neurological Disease
-
适应症——
化学信息
-
CAS Number101831-37-2
-
分子量407.64
-
分子式C17H9Cl3N4O2
-
纯度>98% (HPLC)
-
溶解度DMSO: 16 mg/mL (39.25 mM)
-
SMILESN#CC(C1=CC=C(Cl)C=C1)C2=C(Cl)C=C(N(C(N3)=O)N=CC3=O)C=C2Cl
-
化学全称2-(4-chlorophenyl)-2-(2,6-dichloro-4-(3,5-dioxo-4,5-dihydro-1,2,4-triazin-2(3H)-yl)phenyl)acetonitrile
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1. Oz HS, et al. Int J Clin Med. 2014 Jan 1;5(3):93-10
产品手册
关联产品
-
TAPI 2
ADAM-17 (TACE) and MMP inhibitor (Ki = 120 nM at ADAM-17). Sensitizes cancer stem cells to the lethal effects of 5-FU in vitro. Blocks shedding of TNF-α from cell membranes.
-
IMS2186
IMS2186 是一种抗脉络膜新生血管 (CNV) 试剂。IMS2186 使癌细胞周期阻滞在 G2/M 期,由此发挥抗增殖和抗血管生成作用。IMS2186 无眼内毒性,并能够减少眼睛渗漏和病变细胞的数量。
-
(R)-Nepicastat HCl
(R)-Nepicastat HCl 是 Nepicastat HCl 的 R 对映异构体,是一种有效的选择性抑制剂,对牛和人多巴胺-β-羟化酶的 IC50 分别为 25.1 nM 和 18.3 nM,对 12 种其他酶和 13 种神经递质受体的亲和力可忽略不计。
021-51111890
购物车()
sales@molnova.cn

